Farla Medical Int Ltd - Accounts to registrar (filleted) - small 17.3

Farla Medical Int Ltd - Accounts to registrar (filleted) - small 17.3


IRIS Accounts Production v17.3.1.106 10315891 Board of Directors 8.8.16 31.8.17 31.8.17 false true false false true false Ordinary 1.00000 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure103158912016-08-07103158912017-08-31103158912016-08-082017-08-31103158912016-08-0710315891ns15:EnglandWales2016-08-082017-08-3110315891ns14:PoundSterling2016-08-082017-08-3110315891ns10:Director12016-08-082017-08-3110315891ns10:PrivateLimitedCompanyLtd2016-08-082017-08-3110315891ns10:SmallEntities2016-08-082017-08-3110315891ns10:AuditExempt-NoAccountantsReport2016-08-082017-08-3110315891ns10:SmallCompaniesRegimeForDirectorsReport2016-08-082017-08-3110315891ns10:SmallCompaniesRegimeForAccounts2016-08-082017-08-3110315891ns10:FullAccounts2016-08-082017-08-3110315891ns10:OrdinaryShareClass12016-08-082017-08-3110315891ns10:OrdinaryShareClass112016-08-082017-08-3110315891ns10:Director22016-08-082017-08-3110315891ns10:CompanySecretary12016-08-082017-08-3110315891ns10:RegisteredOffice2016-08-082017-08-3110315891ns5:ShareCapital2017-08-3110315891ns10:OrdinaryShareClass12017-08-3110315891ns5:RetainedEarningsAccumulatedLosses2016-08-082017-08-3110315891ns5:RetainedEarningsAccumulatedLosses2017-08-31


REGISTERED NUMBER: 10315891 (England and Wales)















Unaudited Financial Statements

for the Period 8 August 2016 to 31 August 2017

for

Farla Medical Int Ltd

Farla Medical Int Ltd (Registered number: 10315891)

Contents of the Financial Statements
for the Period 8 August 2016 to 31 August 2017










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


Farla Medical Int Ltd

Company Information
for the Period 8 August 2016 to 31 August 2017







DIRECTORS: Mrs E Zalcberg
N Y Weinberger





SECRETARY:





REGISTERED OFFICE: 5 North End Road
London
NW11 7RJ





REGISTERED NUMBER: 10315891 (England and Wales)





ACCOUNTANTS: Martin+Heller
Chartered Accountants
5 North End Road
London
NW11 7RJ

Farla Medical Int Ltd (Registered number: 10315891)

Balance Sheet
31 August 2017

Notes £   
CURRENT ASSETS
Cash in hand 300
TOTAL ASSETS LESS CURRENT
LIABILITIES

300

CAPITAL AND RESERVES
Called up share capital 3 300
SHAREHOLDERS' FUNDS 300

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 31 August 2017.

The members have not required the company to obtain an audit of its financial statements for the period ended 31 August 2017 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each
financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and
which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable
to the company.

The financial statements have been prepared and delivered in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors on 8 May 2018 and were signed on its behalf by:





N Y Weinberger - Director


Farla Medical Int Ltd (Registered number: 10315891)

Notes to the Financial Statements
for the Period 8 August 2016 to 31 August 2017


1. STATUTORY INFORMATION

Farla Medical Int Ltd is a private company, limited by shares , registered in England and Wales. The company's registered
number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with the provisions of Section 1A "Small Entities" of Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Taxation
Taxation for the period comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent
that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively
enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in
which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted
or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be
recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. CALLED UP SHARE CAPITAL


Allotted, issued and fully paid:
Number: Class: Nominal
value: £   
300 Ordinary £1 300

300 Ordinary shares of £1 each were allotted and fully paid for cash at par during the period.

4. RESERVES
Retained
earnings
£   

Profit for the period -
At 31 August 2017 -